A Random Comparative Study of Terbinafine Versus Griseofulvin in Patients with Tinea Capitis in Western China

Mycopathologia

Volumn 172, Issue 5, 2011, Pages 365-372

  Deng, S ^a   Hu, H ^a   Abliz, P ^a   Wan, Z ^b   Wang, A ^b   Cheng, W ^b   Li, R ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antifungal susceptibility; Griseofulvin; Terbinafine; Tinea capitis; Trichophyton spp; Western China

Indexed keywords

ANTIFUNGAL AGENT; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ADOLESCENT; ARTHRODERMATACEAE; ARTICLE; CHILD; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSPORUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

ADOLESCENT; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GRISEOFULVIN; HUMANS; ITRACONAZOLE; KETOCONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; NAPHTHALENES; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

ARTHRODERMA; ARTHRODERMA VANBREUSEGHEMII; FUNGI; TRICHOPHYTON; TRICHOPHYTON TONSURANS; TRICHOPHYTON VIOLACEUM;

EID: 80053952584     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9438-2     Document Type: Article

References (21)

1. Deng S, Bulmer G, de Hoog GS. Deviating flora of tinea capitis in Western China suggests slow migration rates in dermatophytes. Med Mycol. 2008; 46: 421-7.
2. Roberts B, Friedlander S. Tinea capitis: a treatment update. Pediatr Ann. 2005; 34: 191-200.
3. Elewski BE, Ca′ceres HW, DeLeon L, et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol. 2008; 59: 41-54.
4. Kane J, Summerbell R, Sigler L, Krajden S, Land G, editors. Laboratory handbook of dermatophytes: a clinical guide and laboratory manual of dermatophytes and other filamentous fungi from skin, hair, and nails belmont. CA: Star; 1997. p. 33-44.
5. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidial forming filamentous fungi. Proposed Standard M38-P. Wayne: NCCLS; 1998.
6. Tai S, Tian S, Dong Y. Survey report of pathogens of tinea capitis in Xinjiang, China. J Derm Venereol. 1992; 6: 218.
7. Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol. 1999; 41(1): 60-3.
8. Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole and fluconazole. Pediatr Dermatol. 2001; 18: 433-8.
9. Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, et al. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol. 2001; 144: 321-7.
10. Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children. N Z Med J. 1998; 111: 55-7.
11. Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004; 114: 1312-5.
12. Haroon TS, Hussain I, Aman S, Jahangir M, Kazmi AH, Sami AR, et al. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br J Dermatol. 1996; 135: 86-8.
13. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P, Stewart D, et al. Terbinafine in the treatment of richophyton tinea capitis: a randomized, double-blind, parallel-group, duration finding study. Pediatrics. 2002; 109: 602-7.
14. Jahangir M, Hussain I, Ul Hasan M, Haroon TS. A doubleblind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. Br J Dermatol. 1998; 139: 672-4.
15. Gupta AK, Adam P. Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol. 1998; 15: 56-8.
16. Gan VN, Petruska M, Ginsburg CM. Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin. Pediatr Infect Dis J. 1987; 6: 46-9.
17. Caceres-Rios H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol. 2000; 42: 80-4.
18. Memißolu HR, Erboz S, Akkaya S, Akan T, Aksungur VL, Ünal I, Karakaß M. Comparative study of the efficacy and tolerability of 4 weeks terbinafine therapy with 8 weeks griseofulvin therapy in children with tinea capitis. J Dermatol Treat. 1999; 10: 189-93.
19. Ghannoum MA, Chaturvedi V, Espinel-ingroff A, et al. Intra-and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes to antifungals. J Clin microbial. 2004; 42: 2977-9.
20. Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology. 1998; 197: 361-7.
21. Macura AB. In vitro susceptibility of dermatophytes to antifungal drugs: a comparision of two methods. Int J Dermatol. 1993; 32(7): 533-6.